| Ticker Symbol: | CSCX |
|---|---|
| Exchange: | NASD |
| Contact Info: | 3303 Monte Villa Parkway Bothell WA 98021 425 402-2000 |
| CEO/President: | John R. Hinson |
| Industry: | Medical Products / Standard Industry Code: 3841 |
| Description: | Cardiac Science develops and markets life-saving external cardiac defibrillator devices and proprietary tachyarrhythmia detection software that monitors and automatically treats cardiac arrest victims. The company\'s technology has multiple potential applications, including use in external defibrillators and bedside patient monitors widely used in hospitals throughout the world. |
| Shares Outstanding: | 22,860 (000) | Market Value: | 170,790 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 69.61% | Number of Inst.Shareholders: | 8.40% |
| Last Quarter Sales: | 54.01 ($Mil.) | Last Quarter Net Income: | 2.48 ($Mil.) |
| Last Quarter EPS: | 0.11 | P/E Ratio: | 19 |
| Most Recent Earnings: | Earnings Per Share: | 0.40 | |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| BOSTON SCIENTIF | -25.40 | 8.55 | |
| MEDTRONIC INC | -21.70 | 39.81 | |
| BAXTER INTL INC | -1.10 | 59.35 | |
| ST. JUDE MEDICA | -11.80 | 35.82 | |
| ZIMMER HOLDINGS | -41.20 | 44.35 |
